These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 31191873)

  • 21. Adalimumab Treatment in Women With Moderate-to-Severe Hidradenitis Suppurativa from the Placebo-Controlled Portion of a Phase 2, Randomized, Double-Blind Study.
    Gottlieb A; Menter A; Armstrong A; Ocampo C; Gu Y; Teixeira HD
    J Drugs Dermatol; 2016 Oct; 15(10):1192-1196. PubMed ID: 27741335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TNF-α antagonists beyond approved indications: stories of success and prospects for the future.
    Karampetsou MP; Liossis SN; Sfikakis PP
    QJM; 2010 Dec; 103(12):917-28. PubMed ID: 20802008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Implementation of Biologics and Small Molecules in the Treatment of Hidradenitis Suppurativa.
    Aarts P; Dudink K; Vossen ARJV; van Straalen KR; Ardon CB; Prens EP; van der Zee HH
    Drugs; 2021 Aug; 81(12):1397-1410. PubMed ID: 34283386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biologic Use in Pediatric Patients With Hidradenitis Suppurativa: A Systematic Review.
    Sachdeva M; Kim P; Mufti A; Maliyar K; Sibbald C; Alavi A
    J Cutan Med Surg; 2022; 26(2):176-180. PubMed ID: 34587768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ustekinumab treatment for hidradenitis suppurativa.
    Takeda K; Kikuchi K; Kanazawa Y; Yamasaki K; Aiba S
    J Dermatol; 2019 Dec; 46(12):1215-1218. PubMed ID: 31638283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo.
    Campione E; Lanna C; Diluvio L; Cannizzaro MV; Grelli S; Galluzzo M; Talamonti M; Annicchiarico-Petruzzelli M; Mancini M; Melino G; Candi E; Schiavone G; Wang Y; Shi Y; Bianchi L
    Cell Cycle; 2020 Feb; 19(3):257-267. PubMed ID: 31905036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-17 Inhibition: A Valid Therapeutic Strategy in the Management of Hidradenitis Suppurativa.
    Malvaso D; Calabrese L; Chiricozzi A; Antonelli F; Coscarella G; Rubegni P; Peris K
    Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brodalumab for severe hidradenitis suppurativa: a case of clinico-radiologic improvement and literature review.
    Vagnozzi E; Bruni M; Esposito M; Fargnoli MC
    J Dermatolog Treat; 2023 Dec; 34(1):2270091. PubMed ID: 37842732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Etanercept: effective in the management of hidradenitis suppurativa.
    Cusack C; Buckley C
    Br J Dermatol; 2006 Apr; 154(4):726-9. PubMed ID: 16536817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of action of certolizumab pegol (CDP870): in vitro comparison with other anti-tumor necrosis factor alpha agents.
    Nesbitt A; Fossati G; Bergin M; Stephens P; Stephens S; Foulkes R; Brown D; Robinson M; Bourne T
    Inflamm Bowel Dis; 2007 Nov; 13(11):1323-32. PubMed ID: 17636564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Off-label uses of TNF-a inhibitors and IL-12/23 inhibitors in dermatology.
    Hong JJ; Hadeler EK; Mosca ML; Brownstone ND; Bhutani T; Liao WJ
    Dermatol Online J; 2021 Nov; 27(11):. PubMed ID: 35130397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.
    van Herwaarden N; den Broeder AA; Jacobs W; van der Maas A; Bijlsma JW; van Vollenhoven RF; van den Bemt BJ
    Cochrane Database Syst Rev; 2014 Sep; (9):CD010455. PubMed ID: 25264908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of anti-interleukin-1 therapy in severe hidradenitis suppurativa: a case report.
    van der Zee HH; Prens EP
    Dermatology; 2013; 226(2):97-100. PubMed ID: 23713053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-world Effectiveness of Biologic Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis After Etanercept Discontinuation in the United Kingdom, France, and Germany.
    Li N; Betts KA; Messali AJ; Skup M; Garg V
    Clin Ther; 2017 Aug; 39(8):1618-1627. PubMed ID: 28729087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term successful adalimumab therapy in severe hidradenitis suppurativa.
    Blanco R; Martínez-Taboada VM; Villa I; González-Vela MC; Fernández-Llaca H; Agudo M; González-López MA
    Arch Dermatol; 2009 May; 145(5):580-4. PubMed ID: 19451504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab.
    Harde V; Mrowietz U
    J Dtsch Dermatol Ges; 2009 Feb; 7(2):139-41. PubMed ID: 19371236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic TNF Inhibitors Exhibit Differential Levels of Efficacy in Accelerating Cutaneous Wound Healing.
    Cao Y; Harvey BP; Jin L; Westmoreland S; Wang J; Puri M; Yang Y; Robb HM; Tanriverdi S; Hu C; Wang X; Xin X; Liu Y; Macoritto MP; Smith KM; Tian Y; White K; Radstake TRDJ; Kaymakcalan Z
    JID Innov; 2024 Jan; 4(1):100250. PubMed ID: 38226320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa.
    Kimball AB; Okun MM; Williams DA; Gottlieb AB; Papp KA; Zouboulis CC; Armstrong AW; Kerdel F; Gold MH; Forman SB; Korman NJ; Giamarellos-Bourboulis EJ; Crowley JJ; Lynde C; Reguiai Z; Prens EP; Alwawi E; Mostafa NM; Pinsky B; Sundaram M; Gu Y; Carlson DM; Jemec GB
    N Engl J Med; 2016 Aug; 375(5):422-34. PubMed ID: 27518661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Observational case series on adalimumab-induced paradoxical hidradenitis suppurativa.
    Delobeau M; Abdou A; Puzenat E; Deveza E; Biver-Dalle C; van de Laak A; Roche-Kubler B; Vuitton L; Koch S; Wendling D; Aubin F
    J Dermatolog Treat; 2016; 27(3):251-3. PubMed ID: 26368546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients.
    Scheinfeld N
    Dermatol Online J; 2013 Apr; 19(4):1. PubMed ID: 24021361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.